Sleep
Session
Obstructive sleep apnoea in adults and children
introducing the Cournand Lecture on inflammatory pathway activation by intermittent hypoxia
Aims : To discuss how to recognise the child at risk for sleep-disordered breathing and the associated morbidity, summarise the value of polysomnography and other objective methods in determining severity of sleep-disordered breathing, present a stepwise treatment approach and compare diagnosis and management of sleep-disordered breathing in children and adults.
10:45
Cournand lecture - Inflammatory pathway activation by intermittent hypoxia in obstructive sleep apnoea
S. Ryan(Dublin, Ireland)
COI
1
441
11:25
ERS Statement: Obstructive sleep-disordered breathing in children 2-18 years old. Risk factors, associated morbidity, predictors of persistent disease and assessment of disease severity
A. Kaditis(Athens, Greece)
COI
2
442
11:52
Obstructive sleep-disordered breathing in children 2-18 years old: indications for treatment, stepwise treatment approach and recognition and management of persistent disease
S. Verhulst(Antwerpen, Belgium)
COI
3
443
12:19
Diagnosis and management of OSAS in children and adults: similarities and differences
R. Riha(Edinburgh (Edinburgh), United Kingdom)
COI
4
444
. . .
